CMO: Pharmaceutical Contract Manufacturing Organizations

INSIGHTS ON CONTRACT PHARMA MANUFACTURING

Minimizing API Supply Chain Risks
Partnering with an API CMO can help you navigate challenges you may encounter, ensuring you are using best quality practices and minimizing delays in getting medicines to market that use those APIs.
How Successful CDMO Collaboration Sets The Foundation For Sterile Injectable Product Success
In the realm of Sterile Injectables, sponsors come in a variety of sizes and with a range of experience levels. The same is true for CDMOs, and the dynamics of these outsourcing relationships have a huge influence on project success. Explore how a small or medium size biotech or pharma company can benefit from the experience and assistance provided by a CDMO.
A Fill Finish Manufacturing Partner With Resources, Solutions, And Agility
We offer a unique range of formulation and aseptic filling in vials, prefilled syringes, or cartridges to address production needs that span from small early stage clinical products to larger scale commercial products.
What Is The Benefit Of Doing An Engineering Batch In The Pharmaceutical Industry?
Challenges will inevitably be encountered before or during manufacturing. An engineering batch can help avoid many predictable and unpredictable issues, minimizing cost and time and smoothing the process before commercial production.

Innovating In The Viscosity Design Space For Handheld Combination Products: A New 2.25 mL Autoinjector Platform
5/12/2021

Biologics are contributing to quality-of-life improvements for chronic disease sufferers. Simultaneously, innovations in the drug delivery device space are allowing for chronic disease sufferers to manage their drug therapies from home. Discover an autoinjector platform that reconciles the demands of biologics with safety, reliability, and ease of use during self-injection.
Pharmaceutical Technology Transfer: Problems And Solutions
5/5/2021

Discover tips and instructions to ensure a technology transfer is smoothly and successfully executed with your CMO partner to ensure minimal lot-to-lot variability during routine manufacturing and packaging operations.
Key Considerations For A Successful Pharmaceutical Tech Transfer
5/5/2021

A pharmaceutical technology transfer can also mean knowledge transfer about existing products from one manufacturing site to another by a facility change, a company merger, an acquisition, or a shift to a contract manufacturer (CMO).
What Is The Difference Between Verification And Validation Of Analytical Methods In The Pharmaceutical Industry?
5/5/2021

For a contract manufacturer, one of the first steps in evaluating a technology transfer project is: do we need to perform analytical method verification or method validation? Although method verification and method validation look similar, they are not the same and actually have different requirements.
Scale-Up: The Next Mountain To Climb In Technology Transfers
5/4/2021

Turning a promising drug candidate into a successful pharmaceutical product involves scaling-up the processes so a commercial supply can be achieved, which involves technical hurdles.

More Insights On Contract Pharma Manufacturing

CONTRACT PHARMA MANUFACTURING SOLUTIONS

Quick To Clinic For Biologics: Fact Sheet

The pressure to file an IND makes accelerated Phase I safety testing a priority. With the Quick to Clinic program, Thermo Fisher Scientific can deliver your large molecule drug substance for First-in-Human studies in as little as 12 months. Now you can meet important milestones – such as filing the IND – or secure additional funding with all the confidence your project needs and, we can supply. Because helping you reduce the time it takes to get your discovery to the patients who need it matters, our Quick to Clinic for Biologics is made with speed and flexibility.
Surfactant Analysis Services

Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.
Light Path™ Custom Material Supply: Mammalian And Microbial Custom Services For Protein Production

At Lonza, we understand the challenges facing biotherapeutic and vaccine manufacturers related to the time and costs inherent in the drug discovery and development process. Light Path™ Custom Material Supply Services are efficient, focused technology and production offerings for the Preclinical and Phase I stages of novel biologics development.
Mammalian Cell Culture: Process R&D Services

Lonza’s global R&D center for mammalian cell processes is based in Slough, UK alongside a custom manufacturing facility. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries. Read more about Lonza’s complete range of R&D Services and an array of technologies and skills to best match their customers’ requirements for all stages of product development.
High Potent API And Cytotoxic Capabilities

When it comes to HPAPI, you will notice that we operate with a quiet confidence that comes from years of experience with HPAPI and cytotoxic drug products. At Pii we have learned that every successful HPAPI project begins with a deep understanding of the data.